Compugen Ltd SEC filings CGEN
Compugen Ltd has 607 filings in SEC EDGAR's recent list, going back to Feb 13, 2001. Its latest annual report, Form 20-F, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 10, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Mar 2, 2026 | Dec 31, 2025 |
| 20-F | Annual report (foreign issuer) | Mar 4, 2025 | Dec 31, 2024 |
| 20-F | Annual report (foreign issuer) | Mar 5, 2024 | Dec 31, 2023 |
| 20-F/A | Amended annual report (foreign issuer) | Aug 23, 2023 | Dec 31, 2022 |
| 20-F | Annual report (foreign issuer) | Feb 28, 2023 | Dec 31, 2022 |
| 20-F/A | Amended annual report (foreign issuer) | Feb 28, 2022 | Dec 31, 2021 |
| 20-F | Annual report (foreign issuer) | Feb 28, 2022 | Dec 31, 2021 |
| 20-F | Annual report (foreign issuer) | Feb 25, 2021 | Dec 31, 2020 |
| 20-F/A | Amended annual report (foreign issuer) | Feb 27, 2020 | Dec 31, 2019 |
| 20-F | Annual report (foreign issuer) | Feb 24, 2020 | Dec 31, 2019 |
| 20-F | Annual report (foreign issuer) | Mar 21, 2019 | Dec 31, 2018 |
| 20-F | Annual report (foreign issuer) | Mar 27, 2018 | Dec 31, 2017 |
| 20-F | Annual report (foreign issuer) | Feb 16, 2017 | Dec 31, 2016 |
| 20-F | Annual report (foreign issuer) | Mar 7, 2016 | Dec 31, 2015 |
| 20-F | Annual report (foreign issuer) | Mar 12, 2015 | Dec 31, 2014 |
| 20-F | Annual report (foreign issuer) | Feb 18, 2014 | Dec 31, 2013 |
| 20-F | Annual report (foreign issuer) | Mar 21, 2013 | Dec 31, 2012 |
| 20-F | Annual report (foreign issuer) | Mar 14, 2012 | Dec 31, 2011 |
| 20-F | Annual report (foreign issuer) | Mar 21, 2011 | Dec 31, 2010 |
| 20-F | Annual report (foreign issuer) | Mar 11, 2010 | Dec 31, 2009 |
| 20-F | Annual report (foreign issuer) | Mar 18, 2009 | Dec 31, 2008 |
| 20-F | Annual report (foreign issuer) | Apr 3, 2008 | Dec 31, 2007 |
| 20-F | Annual report (foreign issuer) | Apr 18, 2007 | Apr 18, 2007 |
| 20-F | Annual report (foreign issuer) | Mar 27, 2006 | Mar 27, 2006 |
| 20-F | Annual report (foreign issuer) | Feb 28, 2005 | Dec 31, 2004 |
| 20-F | Annual report (foreign issuer) | Apr 7, 2004 | Dec 31, 2003 |
| 20-F | Annual report (foreign issuer) | Jun 9, 2003 | Dec 31, 2002 |
| 20-F | Annual report (foreign issuer) | Apr 15, 2002 | Dec 31, 2001 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CGEN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Holon, Israel
- SEC filer status
- Accelerated filer
- SEC CIK
- 1119774
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.